Hospital de Meixoeiro Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2013
NCT01642134
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Andres Iñiguez Romo, MD, PhD

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aortic Valve Stenosis (Phase 4)

Embolism (Phase 4)

Intracranial Embolism (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3